You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Research conducted by for-profit companies shouldn't be dismissed out of hand as hopelessly biased, the University of Pennsylvania's Ravi Parikh writes in an op-ed at the Washington Post.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?Login Now.
Don't have a GenomeWeb or 360Dx account?Register for Free.
The Wall Street Journal reports that Russia's announcement of a coronavirus vaccine approval was met with concern as safety testing has not yet been completed.
New Scientist writes there aren't much data available on the accuracy of the two rapid COVID-19 tests the UK plans to roll out.
In PNAS this week: downstream effect of oncoprotein fusion, epigenetic changes influence tRNAs in colon cancer, and more.
Nature News reports that recent proposed changes to the US National Science Foundation have raised concerns about a shift away from the agency's focus on basic research.
This webinar will discuss a study that combined single-cell gene expression and spatial gene expression to understand the evolution of sepsis in the kidney at the cellular and molecular level.
As worldwide COVID-19 cases continue to rise, there is a significant need to increase testing and population surveillance capacity.